# Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

> **NCT01038401** · NA · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 30 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **PROCEDURE:** GI endoscopy and GALT biopsies
- **BIOLOGICAL:** A sample of venous blood will also be collected

## Key facts

- **NCT ID:** NCT01038401
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038401, "Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01038401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*